These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 1372318

  • 1. Effects of analogs of 1,25(OH)2 vitamin D3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4.
    Clark JW, Posner MR, Marsella JM, Santos A, Uskokovic M, Eil C, Lasky SR.
    J Cancer Res Clin Oncol; 1992; 118(3):190-4. PubMed ID: 1372318
    [Abstract] [Full Text] [Related]

  • 2. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
    Siu-Caldera ML, Clark JW, Santos-Moore A, Peleg S, Liu YY, Uskoković MR, Sharma S, Reddy GS.
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
    [Abstract] [Full Text] [Related]

  • 3. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
    Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, Andreeff M, Koeffler HP.
    Blood; 1996 Sep 15; 88(6):2201-9. PubMed ID: 8822940
    [Abstract] [Full Text] [Related]

  • 4. Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4.
    Lasky SR, Bell W, Huhn RD, Posner MR, Wiemann M, Calabresi P, Eil C.
    Cancer Res; 1990 May 15; 50(10):3087-94. PubMed ID: 2159372
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metabolism of the cell differentiating agent 1alpha,25(OH)2-16-ene-23-yne vitamin D3 by leukemic cells.
    Satchell DP, Norman AW.
    J Steroid Biochem Mol Biol; 1996 Jan 15; 57(1-2):117-24. PubMed ID: 8645610
    [Abstract] [Full Text] [Related]

  • 8. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP.
    Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a vitamin D3-resistant human chronic myelogenous leukemia cell line.
    Lasky SR, Posner MR, Iwata K, Santos-Moore A, Yen A, Samuel V, Clark J, Maizel AL.
    Blood; 1994 Dec 15; 84(12):4283-94. PubMed ID: 7994044
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific.
    Zhao J, Tan BK, Marcelis S, Verstuyf A, Bouillon R.
    J Steroid Biochem Mol Biol; 1996 Feb 15; 57(3-4):197-202. PubMed ID: 8645629
    [Abstract] [Full Text] [Related]

  • 11. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
    Inaba M, Okuno S, Nishizawa Y, Yukioka K, Otani S, Matsui-Yuasa I, Morisawa S, DeLuca HF, Morii H.
    Arch Biochem Biophys; 1987 Nov 01; 258(2):421-5. PubMed ID: 2823715
    [Abstract] [Full Text] [Related]

  • 12. Effect of 1,25-dihydroxyvitamin D3 and its analogs on human immunodeficiency virus infection in monocytes/macrophages.
    Kizaki M, Ikeda Y, Simon KJ, Nanjo M, Koeffler HP.
    Leukemia; 1993 Oct 01; 7(10):1525-30. PubMed ID: 7692190
    [Abstract] [Full Text] [Related]

  • 13. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.
    Zhou JY, Norman AW, Chen DL, Sun GW, Uskokovic M, Koeffler HP.
    Proc Natl Acad Sci U S A; 1990 May 01; 87(10):3929-32. PubMed ID: 2339131
    [Abstract] [Full Text] [Related]

  • 14. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R, Subhashini J, Roy KR, Reddy GS, Robinson M, Uskokovic MR, Venkateswara Reddy G, Reddanna P.
    J Cell Biochem; 2008 Aug 01; 104(5):1832-42. PubMed ID: 18348265
    [Abstract] [Full Text] [Related]

  • 15. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 01; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 16. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS, Rao DS, Siu-Caldera ML, Astecker N, Weiskopf A, Vouros P, Sasso GJ, Manchand PS, Uskokovic MR.
    Arch Biochem Biophys; 2000 Nov 15; 383(2):197-205. PubMed ID: 11185554
    [Abstract] [Full Text] [Related]

  • 17. Synergistic effect of 1,25-dihydroxyvitamin D3 and retinoic acid in inducing U937 cell differentiation.
    Tanaka Y, Shima M, Yamaoka K, Okada S, Seino Y.
    J Nutr Sci Vitaminol (Tokyo); 1992 Oct 15; 38(5):415-26. PubMed ID: 1284131
    [Abstract] [Full Text] [Related]

  • 18. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
    Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca HF.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5624-8. PubMed ID: 6594194
    [Abstract] [Full Text] [Related]

  • 19. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS.
    J Pharmacol Exp Ther; 1995 Dec 15; 275(3):1254-60. PubMed ID: 8531089
    [Abstract] [Full Text] [Related]

  • 20. Biological evaluation of epoxy analogs of 1 alpha,25-dihydroxyvitamin D3.
    Allewaert K, Zhao XY, Zhao J, Glibert F, Branisteanu D, De Clercq P, Vandewalle M, Bouillon R.
    Steroids; 1995 Apr 15; 60(4):324-32. PubMed ID: 8539786
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.